Shares of Alaska Air Group (NYSE: ALK) were up 1.3% in afternoon trade on Thursday. The stock dropped 5% over the past three months but has gained 4% in the past one week. It is currently trading 7% below its 52-week high of $72.22.
The company operates in a highly competitive industry and faces several risks such as economic conditions, volatility in fuel prices and unexpected aircraft incidents. Alaska’s revenue initiatives, particularly its Saver Fare product, as well as its network expansion efforts helped drive revenue and capacity growth in 2019.
The airline also saw a 2% increase in unit costs, ex fuel and special items, during 2019. This increase is expected to continue in 2020 due to wage inflation, higher engine maintenance on some of its fleets, and higher lease return costs associated with its Airbus fleet.
Alaska is focused on reducing its overhead, improving its productivity and managing its vendor costs. The company is also taking steps to manage its fuel costs by flying bigger, more fuel-efficient aircraft thereby improving its fuel efficiency.
In 2019, Alaska saw a 6% growth in total revenues with a 4.2% increase in unit revenues. Capacity increased 2%, fueled by network expansion and fleet growth. The aforementioned revenue initiatives are expected to drive incremental revenue in 2020 as well.
Alaska expects to increase its network capacity by approx. 3-4% in 2020, but this guidance is heavily dependent on the return to service of the Boeing 737 Max aircraft. The company currently expects 10 737 Max aircraft to be delivered in 2020 but if the grounding delays these deliveries, the capacity growth might be negatively impacted.
Analysts are forecasting earnings of $7.04 per share on revenue of $9.18 billion for 2020. The majority of analysts have rated the stock as Buy and it has an average price target of $76.60, representing an upside of 15% from the current level.
Most Popular
GIS Earnings: All you need to know about General Mills’ Q1 2025 earnings results
General Mills, Inc. (NYSE: GIS) reported its first quarter 2025 earnings results today. Net sales decreased 1% year-over-year to $4.8 billion. Organic sales were down 1%. Net earnings attributable to
Guardian Pharmacy seeks to raise up to $108 mil in US IPO
Joining the wave of healthcare IPOs this year, amid Fed rate cut expectations, Guardian Pharmacy Services, Inc. is preparing to go public. In a statement filed with the Securities and
Earnings Preview: Will Micron (MU) maintain recovery momentum in Q4?
After recovering from a rough patch, Micron Technology Inc. (NASDAQ: MU) is preparing to report fourth-quarter results next week, even as the market keeps a close watch on the event